Williams Jones Wealth Management LLC. Lowers Stock Holdings in Cryoport, Inc. (NASDAQ:CYRX)

Williams Jones Wealth Management LLC. lowered its holdings in shares of Cryoport, Inc. (NASDAQ:CYRX) by 9.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 76,898 shares of the company’s stock after selling 7,781 shares during the quarter. Williams Jones Wealth Management LLC. owned approximately 0.16% of Cryoport worth $1,361,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Natixis Investment Managers International lifted its position in shares of Cryoport by 61.5% in the fourth quarter. Natixis Investment Managers International now owns 4,536 shares of the company’s stock valued at $70,000 after acquiring an additional 1,727 shares in the last quarter. Quest Partners LLC purchased a new position in shares of Cryoport in the fourth quarter valued at approximately $202,000. Arizona State Retirement System lifted its position in shares of Cryoport by 5.4% in the fourth quarter. Arizona State Retirement System now owns 13,665 shares of the company’s stock valued at $212,000 after acquiring an additional 696 shares in the last quarter. Inspire Investing LLC purchased a new position in shares of Cryoport in the first quarter valued at approximately $358,000. Finally, Victory Capital Management Inc. lifted its position in shares of Cryoport by 25.2% in the fourth quarter. Victory Capital Management Inc. now owns 42,716 shares of the company’s stock valued at $662,000 after acquiring an additional 8,600 shares in the last quarter. Hedge funds and other institutional investors own 92.90% of the company’s stock.

Insider Activity at Cryoport

In other Cryoport news, Director Richard J. Berman sold 8,105 shares of the business’s stock in a transaction on Wednesday, May 15th. The stock was sold at an average price of $13.41, for a total value of $108,688.05. Following the completion of the transaction, the director now directly owns 100,000 shares in the company, valued at approximately $1,341,000. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Cryoport news, insider Edward J. Zecchini sold 3,443 shares of the company’s stock in a transaction dated Tuesday, May 14th. The shares were sold at an average price of $13.37, for a total value of $46,032.91. Following the completion of the transaction, the insider now directly owns 60,051 shares of the company’s stock, valued at approximately $802,881.87. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Richard J. Berman sold 8,105 shares of the company’s stock in a transaction dated Wednesday, May 15th. The shares were sold at an average price of $13.41, for a total transaction of $108,688.05. Following the completion of the transaction, the director now directly owns 100,000 shares of the company’s stock, valued at $1,341,000. The disclosure for this sale can be found here. 10.10% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Jefferies Financial Group assumed coverage on Cryoport in a research report on Thursday, April 4th. They set a “buy” rating and a $21.00 price target for the company. Needham & Company LLC reiterated a “buy” rating and issued a $18.00 target price on shares of Cryoport in a report on Wednesday, May 8th. Finally, B. Riley lowered Cryoport from a “buy” rating to a “neutral” rating and decreased their target price for the company from $22.00 to $19.00 in a report on Friday, May 3rd. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $19.43.

Cryoport Price Performance

CYRX stock traded up $1.17 on Tuesday, reaching $8.60. The company had a trading volume of 1,441,177 shares, compared to its average volume of 575,645. Cryoport, Inc. has a 1 year low of $5.32 and a 1 year high of $20.10. The company has a debt-to-equity ratio of 0.86, a quick ratio of 10.22 and a current ratio of 10.73. The company’s fifty day moving average is $9.89 and its 200 day moving average is $13.98. The company has a market cap of $423.64 million, a P/E ratio of -3.19 and a beta of 1.59.

Cryoport (NASDAQ:CYRX) last posted its earnings results on Tuesday, May 7th. The company reported ($0.43) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.37) by ($0.06). Cryoport had a negative net margin of 50.17% and a negative return on equity of 15.19%. The company had revenue of $54.59 million during the quarter, compared to analysts’ expectations of $58.78 million. During the same period in the previous year, the company posted ($0.16) EPS. Cryoport’s quarterly revenue was down 13.1% compared to the same quarter last year. On average, research analysts forecast that Cryoport, Inc. will post -1.34 earnings per share for the current year.

Cryoport Company Profile

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.